NR 602 -Bronchiolitis Case Assignment

NR 602 -Bronchiolitis Case Assignment

NR 602 -Bronchiolitis Case Assignment

• What is the most common cause of Bronchiolitis?

Bronchiolitis is an acute inflammation of the bronchioles, the narrow, thin-walled airways that branch off the bronchi. The usual cause of bronchiolitis is a viral infection such as respiratory syncytial virus (RSV) (Caple & Smith, 2018).

 

• What are some ways to prevent Bronchiolitis?

There are several ways to prevent severe bronchiolitis:

• Avoid smoking in the child’s home because this increases the risk of respiratory illness (Nierengarten, 2015).
• Wash hands frequently with soap and water, especially before touching an infant. If hand washing is not available then use alcohol-based hand sanitizer rubs (Nierengarten, 2015).
• Avoid other adults and children with upper respiratory infection. It may be difficult or impossible to completely avoid persons who are ill, although parents can try to limit direct contact. In addition, infants or children who are sick should not be sent to day care or school because this can potentially cause others to become ill (Nierengarten, 2015).
• A yearly vaccination for influenza virus is recommended for everyone older than six months, especially for household contacts of children younger than five years, and out-of-home caregivers of children younger than five years (Nierengarten, 2015).
• Infants who are younger than 24 months with specific types of chronic lung disease and infants who are younger than 12 months who were born before 29 weeks, have specific types of heart disease, or have other risk factors for severe respiratory syncytial virus (RSV) infection may be given a special medication (palivizumab) to prevent severe RSV infection requiring hospitalization. Palivizumab (brand name: Synagis) is a monoclonal antibody that protects the lungs from severe infection from RSV. It is given as an injection into the muscle once per month for five months starting before RSV season. There is a low risk of serious side effects with palivizumab (Nierengarten, 2015).

 

• What is the main treatment of Bronchiolitis?

Bronchiolitis typically lasts for two to three weeks. The majority of children with bronchiolitis can be cared for at home with supportive care (Giordano, et, al., 2018). …

KINDLY ORDER NOW FOR A CUSTOM-WRITTEN, PLAGIARISM-FREE PAPER

Reference :

Caple, C. R. B. M., & Smith, N. R. M. C. (2018). Bronchiolitis: Respiratory Syncytial Virus. CINAHL Nursing Guide. Retrieved from https://chamberlainuniversity.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=nup&AN=T703084&site=eds-live&scope=site

Nierengarten, M. B. (2015). Bronchiolitis guidelines: Diagnosis, management, and prevention. Contemporary Pediatrics, 32(1), 20–22. Retrieved from https://chamberlainuniversity.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107814300&site=eds-live&scope=site

Giordano, S., Di Gangi, M., Failla, M. C., Bruno, L., Falcone, V., & Dones, P. (2018). Respiratory syncytial virus bronchiolitis and hypertransaminasemia. Le Infezioni In Medicina: Rivista Periodica Di Eziologia, Epidemiologia, Diagnostica, Clinica E Terapia Delle Patologie Infettive, 26(1), 81–84. Retrieved from https://chamberlainuniversity.idm.oclc.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=29525802&site=eds-live&scope=site